ADBI appoints a new director of communications and project manager.IRVINE, Calif.--(BUSINESS WIRE)--March 12, 1997--Allied Biotechnology International Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ADBI ADBI Asian Development Bank Institute ) Wednesday announced the addition of two new staff members. Carmen A. Lodise is the company's new director of communications Director of Communications is a position in the private and public sectors. The Director of Communications is responsible for managing and directing an organization's internal and external communications. . Lodise is responsible for public relations and in-house research on marketing, economic, and financial issues. He also writes the company newsletter and annual reports. He is the liaison to the company's current investor/PR firm Corporate Imaging. Lodise is an economist and journalist who recently spent three years (1992-95) as the finance editor of Mexico's English-language daily newspaper, the Mexico City News, during the period the North American Free Trade Agreement North American Free Trade Agreement (NAFTA), accord establishing a free-trade zone in North America; it was signed in 1992 by Canada, Mexico, and the United States and took effect on Jan. 1, 1994. (NAFTA NAFTA in full North American Free Trade Agreement Trade pact signed by Canada, the U.S., and Mexico in 1992, which took effect in 1994. Inspired by the success of the European Community in reducing trade barriers among its members, NAFTA created the world's ) was being negotiated and implemented. Previously, Lodise was the managing editor of The Corporate Growth Report, a Santa Barbara, Calif.-based monthly magazine on corporate growth strategies (1989-92), and Publisher of a weekly general-interest newspaper in Santa Barbara (1986-89). James Roger Smith is the company's new project manager in the diagnostic division where he is responsible for quality assurance for the company's line of diagnostic assays. He is also a key link in the company's research and development program. Dr. Smith recently received his Ph.D. in pharmacology and toxicology from the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). , Irvine, where he specialized in cardiovascular pharmacology. Smith's research concentrated on exploring the mechanisms that could underlie coronary artery vasospasm coronary artery vasospasm Acute coronary insufficiency, anterior chest wall syndrome, coronary artery spasm, coronary vasoconstriction, Prinzmetal's angina, variant angina, vasospastic angina Cardiology A condition characterized by sudden and usually transient , an important component of heart attacks. While at UC Irvine, Smith received several academic honors, including the Excellence in Research Award from the School of Biological Sciences. Smith has co-authored several scientific articles and a number of abstracts in the fields of pharmacology and nephrology. Allied Biotechnology International Inc., is dedicated to the development of products for the healthcare industry, and positioned to compete in the world market for healthcare biopharmaceutical products. -0- Corporate Advertising and Public Relations handled by Corporate Imaging. -0- NOTE TO EDITORS: Information herein was derived from sources believed to be reliable. No assurance can be made that the information is accurate. CONTACT: Corporate Imaging Inc., Phoenix Neil Rand or Deborah Lange, 602/504-9230 Fax: 602/504-9252 |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion